首页> 美国卫生研究院文献>Geriatrics >Cannabinoids in the Older Person: A Literature Review
【2h】

Cannabinoids in the Older Person: A Literature Review

机译:老年人中的大麻素:文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Medical cannabinoids have received significant mainstream media attention in recent times due to an evolving political and clinical landscape. Whilst the efficacy of cannabinoids in the treatment of some childhood epilepsy syndromes is increasingly recognized, medical cannabinoids may also have potential clinical roles in the treatment of older adults. Prescribing restrictions for medical cannabinoids in certain jurisdictions (including the UK) has recently been relaxed. However, few geriatricians have the detailed knowledge or awareness of the potential risks or rewards of utilizing cannabinoids in the older person; even fewer geriatricians have direct experience of using these drugs in their own clinical practice. Older persons are more likely to suffer from medical illness representing potential indications for medical cannabinoids (e.g., pain); equally they may be more vulnerable to any adverse effects. Aim: This narrative literature review aims to provide a brief introduction for the geriatrician to the potential indications, evidence-base, contra-indications and side effects of medical cannabinoids in older people. Methods: A search was conducted of CENTRAL, Medline, Embase, CINAHL and psycINFO, Cochrane and Web of Science databases. Reference lists were hand searched. Abstracts and titles were screened, followed by a full text reading of relevant articles. Results: 35 studies were identified as relevant for this narrative review. Conclusions: Cannabinoids demonstrate some efficacy in the treatment of pain and chemotherapy-related nausea; limited data suggest potential benefits in the treatment of spasticity and anxiety. Risks of cannabinoids in older patients appear to be moderate, and their frequency comparable to other analgesic drug classes. However, the quality of research is weak, and few older patients have been enrolled in cannabinoid studies. Dedicated research is needed to determine the efficiency and safety of cannabinoids in older patients.
机译:简介:由于政治和临床环境的不断发展,医用大麻素近年来受到了主流媒体的广泛关注。尽管大麻素在治疗某些儿童癫痫综合征中的功效已得到越来越多的认可,但医用大麻素在老年人治疗中也可能具有潜在的临床作用。最近放宽了某些司法管辖区(包括英国)对医用大麻素的限制规定。但是,很少有老年医生对老年人使用大麻素的潜在风险或回报有全面的了解或认识。在自己的临床实践中使用这种药物的直接经验甚至更少。老年人更有可能患上医疗疾病,这代表着医疗大麻素的潜在适应症(例如,疼痛);同样,他们可能更容易受到任何不利影响。目的:本篇叙事性文献综述旨在为老年人提供关于医用大麻素对老年人的潜在适应症,证据基础,禁忌症和副作用的简要介绍。方法:对CENTRAL,Medline,Embase,CINAHL和psycINFO,Cochrane和Web of Science数据库进行搜索。手工搜索参考清单。筛选摘要和标题,然后阅读相关文章的全文。结果:35项研究被确定与此叙事回顾相关。结论:大麻素在治疗疼痛和化疗相关的恶心方面具有一定疗效。有限的数据表明在治疗痉挛和焦虑症方面有潜在的益处。老年患者中大麻素的风险似乎中等,其发生频率可与其他镇痛药类别相提并论。但是,研究质量较弱,几乎没有老年患者参加过大麻素研究。需要进行专门的研究来确定老年患者中大麻素的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号